Science and Technology Facilities Council
Could computers be the next tool to help tackle hospital superbugs?
6th June 2019 – Hospital superbugs such as MRSA or E.coli could soon be under attack from a new generation of drugs designed with the help of advanced computing technologies from STFC and IBM Research.
Superbugs are becoming steadily more resistant to antibiotics, causing an ‘antibiotics crisis’ and a serious threat to public health. In Europe alone 25,000 deaths were linked to antibiotic resistance in 2014. The World Health Organisation estimates that by 2050 this figure will rise to 392,000 and that, worldwide, 10 million people will die from untreatable superbugs.
Speaking at the World Economic Forum earlier this year Matt Hancock, the UK Secretary of State for Health, said: “Antimicrobial resistance is as big a danger to humanity as climate change or warfare.”
Now computational scientists from STFC’s Scientific Computing Department (SCD), STFC Hartree Centre and IBM Research are working together to understand how antibiotic agents operate at the molecular level, and enable the first steps in the efficient design of next generation drugs and treatments. Their findings are published in Physical Review Letters.
Using ultra-largescale computer simulations, which were run on supercomputers at the Hartree Centre, the team has shown that mechanical stresses on cells can affect the apparent potency of simple antibiotics.
Some antibacterial agents kill microorganisms by attacking their cell membranes, leading to leakage and death of the cell. But the amount of tension in the cell membrane can make a difference.
SCD’s Dr Martyn Winn yesterday explained:
“Imagine the cell as a balloon, where the balloon ‘skin’ is the membrane protecting the bacterium inside. As the bacterium grows the membrane stretches and, like a balloon, it’s easier to poke holes into it. Agents such as antimicrobial peptides, naturally occurring molecules that our bodies produce as a first line of defence against bacteria and viruses, are then more able to launch a successful attack, tearing holes in the membrane and causing the bacterium to leak and effectively bleed to death.”
This penetration of the membrane also allows for drugs to infiltrate the cell. Lead author Dr Valeria Losasso from SCD yesterday said:
“How antibiotic molecules penetrate and disrupt bacterial membranes is closely related to the permeation of membranes, required to deliver drugs to targets inside the cell. Both require the membrane barrier to be overcome. Our results may therefore have a wider impact on drug delivery, for example how molecules cross cellular barriers before they reach the circulatory system.”
The design of drugs which target microbial membranes is seen as a promising strategy, which scientists will continue to investigate.
The study was funded through the STFC Hartree Centre’s Innovation Return on Research (IROR) programme. IROR is a collaborative programme between the STFC Hartree Centre and IBM Research, developing digital assets which aim to address key industry challenges identified by real businesses.
Latest News from
Science and Technology Facilities Council
Five high-tech businesses locate to STFC's Daresbury Laboratory22/09/2020 13:05:00
Five pioneering early stage businesses have located their businesses at Daresbury Laboratory where cutting edge research facilities, on-site expertise and business support will help them take their businesses to the next level.
World-first technology goes with the grain21/09/2020 13:05:00
Scottish start-up Crover unveils world-first technology at the TechCrunch Start-up Battlefield 2020.
STFC helps scientists find hints of life on Venus16/09/2020 13:05:00
An international team of astronomers, led by the UK, recently (14 September2020) announced the discovery of a rare molecule in the clouds of Venus that hints at the presence of microbial life.
STFC laser helps reveal properties of superbug killer16/09/2020 10:25:00
Scientists have used high resolution microscopy techniques at STFC’s Octopus imaging cluster to investigate the properties of a compound which kills antibiotic-resistant superbugs.
Planners Fast Track UK's Vaccines Manufacturing and Innovation Centre10/09/2020 13:05:00
The Vaccines Manufacturing and Innovation Centre (VMIC) will be a highly specialist facility located at Harwell Science and Innovation Campus, playing a critical role for the UK in manufacturing vaccines for COVID-19 and beyond.
What do microscopy and astronomy have in common?04/09/2020 11:38:00
… cool tech that helps us to see more clearly through 3D biological tissue samples and into the Universe.
Ripples from deep in the cosmos reveals most massive black hole detected yet03/09/2020 15:20:00
The most massive gravitational-wave source yet has been detected – a binary black hole merger, which produced a blast equal to the energy of eight Suns, sending shockwaves through the universe.
STFC spin-out acquired03/09/2020 13:33:00
vivaMOS Ltd, a high-growth potential, UK tech firm spun out of the Science and Technology Facilities Council (STFC) in 2015, has been acquired by a US multinational. Nordson Corporation, a global precision technology company, announced the acquisition recently (01 September 2020).
STFC welcomes six new start-ups to its national space-tech business programme19/08/2020 12:05:00
The Science and Technology Facilities Council (STFC) has announced six pioneering UK start-ups that have successfully secured a place on the world’s largest business incubation programme for space tech start-ups.